| abstract |
The patent relates to derivatives of deazapurins, thienopyrimidines and fuopyrimidines with a zinc-binding group and their use in the treatment of diseases and disorders associated with phosphoinositide-3-kinase, such as cancer. This application also relates to the treatment of disorders and diseases associated with histone deacetylase and associated with both histone deacetylase and phosphoinositide-3-kinase. |